{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:05:51Z","timestamp":1791230751198,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1378\/chest.14-2764","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T16:47:25Z","timestamp":1423759645000},"page":"499-506","source":"Crossref","is-referenced-by-count":215,"title":["Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease"],"prefix":"10.1016","volume":"148","author":[{"given":"Julie V.","family":"Philley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Richard J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeana L.","family":"Benwill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Taskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Brown-Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foram","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Aksamit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1378\/chest.14-2764_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1164\/rccm.200805-686OC","article-title":"Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome","volume":"178","author":"Kim","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.14-2764_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0272-5231(02)00022-9","article-title":"Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease","volume":"23","author":"Aksamit","year":"2002","journal-title":"Clin Chest Med"},{"issue":"5","key":"10.1378\/chest.14-2764_bib3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/ajrccm.149.5.8173775","article-title":"Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease","volume":"149","author":"Wallace","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.14-2764_bib4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1378\/chest.107.4.1035","article-title":"Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS","volume":"107","author":"Dautzenberg","year":"1995","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.14-2764_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/clinids\/23.5.983","article-title":"Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus","volume":"23","author":"Griffith","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1378\/chest.14-2764_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [published correction appears in Am J Respir Crit Care Med. 2007;175(7):744-745]","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1378\/chest.14-2764_bib7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2217\/fmb.10.50","article-title":"TMC207: the first compound of a new class of potent antituberculosis drugs","volume":"5","author":"Matteelli","year":"2010","journal-title":"Future Microbiol"},{"issue":"9728","key":"10.1378\/chest.14-2764_bib8","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study","volume":"375","author":"Dheda","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1378\/chest.14-2764_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","article-title":"Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis","volume":"9","author":"Orenstein","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1378\/chest.14-2764_bib10","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1128\/AAC.00181-07","article-title":"In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor","volume":"51","author":"Huitric","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1378\/chest.14-2764_bib11","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1128\/AAC.00689-09","article-title":"ATP synthase inhibition of Mycobacterium avium is not bactericidal","volume":"53","author":"Lounis","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1378\/chest.14-2764_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJMoa1313865","article-title":"Multidrug-resistant tuberculosis and culture conversion with bedaquiline","volume":"371","author":"Diacon","year":"2014","journal-title":"N Engl J Med"},{"issue":"RR-09","key":"10.1378\/chest.14-2764_bib13","first-page":"1","article-title":"Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"10.1378\/chest.14-2764_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMp1314385","article-title":"FDA approval of bedaquiline\u2014the benefit-risk balance for drug-resistant tuberculosis","volume":"371","author":"Cox","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1378\/chest.14-2764_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.200603-450OC","article-title":"Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease","volume":"174","author":"Griffith","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.14-2764_bib16","first-page":"30","article-title":"Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease","volume":"11","author":"Olivier","year":"2014","journal-title":"Ann Am Soc"},{"issue":"1","key":"10.1378\/chest.14-2764_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2229-516X.112228","article-title":"Bedaquiline: first FDA-approved tuberculosis drug in 40 years","volume":"3","author":"Mahajan","year":"2013","journal-title":"Int J Appl Basic Med Res"},{"issue":"6","key":"10.1378\/chest.14-2764_bib18","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1086\/515328","article-title":"A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae","volume":"177","author":"Prammananan","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1378\/chest.14-2764_bib19","series-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard-Second Edition","author":"Woods","year":"2011"},{"issue":"4","key":"10.1378\/chest.14-2764_bib20","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1378\/chest.14-2764_bib21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1128\/AAC.40.7.1676","article-title":"Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus","volume":"40","author":"Wallace","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1378\/chest.14-2764_bib22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.13-2538","article-title":"Macrolide\/Azalide therapy for nodular\/bronchiectatic Mycobacterium avium complex lung disease","volume":"146","author":"Wallace","year":"2014","journal-title":"Chest"},{"issue":"12","key":"10.1378\/chest.14-2764_bib23","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/JCM.41.12.5699-5708.2003","article-title":"-rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria","volume":"41","author":"Ad\u00e9kambi","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1378\/chest.14-2764_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/JCM.33.1.149-153.1995","article-title":"PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria","volume":"33","author":"Steingrube","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1378\/chest.14-2764_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/JCM.31.2.175-178.1993","article-title":"Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis","volume":"31","author":"Telenti","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1378\/chest.14-2764_bib26","unstructured":"Olivier K, Daley C, Smith A, Jones P, Davis M, Guntapaldi T, et al. A controlled study of liposomal amikacin for inhalation in patients with recalcitrant nontuberculous mycobacterial lung disease. Paper presented at: American Thoracic Society Annual Meeting; May 16-25, 2014; San Diego, CA."},{"issue":"2","key":"10.1378\/chest.14-2764_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1370\/afm.1601","article-title":"Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death.","volume":"12","author":"Rao","year":"2014","journal-title":"Ann Fam Med"},{"issue":"20","key":"10.1378\/chest.14-2764_bib28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.14-2764_bib29","doi-asserted-by":"crossref","first-page":"f1235","DOI":"10.1136\/bmj.f1235","article-title":"Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies","volume":"346","author":"Schembri","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1378\/chest.14-2764_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tube.2008.08.003","article-title":"Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system","volume":"89","author":"Milano","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"10.1378\/chest.14-2764_bib31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.00142914","article-title":"A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment","volume":"45","author":"Somoskovi","year":"2015","journal-title":"Eur Respir J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T23:30:39Z","timestamp":1598743839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215503462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0012369215503462"],"URL":"https:\/\/doi.org\/10.1378\/chest.14-2764","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}